AWARENESS ABOUT HPV VACCINATION IN WOMEN AND THEIR ATTITUDE IN WESTERN UTTAR PRADESH

Main Article Content

Dr Bharti Maheshwari
Dr Nikita Garkhel
Dr Preeti Sharma

Keywords

HPV vaccine, Cervical cancer, Awareness

Abstract

Introduction: Cervical cancer is the second most common malignancy among Indian women, primarily caused by human papillomavirus (HPV) infection. Despite the availability of a safe and effective HPV vaccine, uptake in India remains low due to limited awareness, cultural barriers, and inadequate public health outreach. The Objective of the study is to assess the level of knowledge, awareness, and acceptance of HPV vaccination among young women and identify key barriers affecting vaccine uptake and screening participation.


Materials and Methods: A cross-sectional study was conducted from June to December 2024 at Muzaffarnagar Medical College, involving 200 women aged 13–25 years attending the Obstetrics and Gynecology OPD. Data were collected through a pretested semi-structured questionnaire assessing knowledge of cervical cancer, risk factors, awareness of HPV vaccination, and attitudes towards vaccine acceptance. Statistical analysis was done using SPSS version 26.


Results: The majority (64.5%) identified cervical cancer as an abnormal cell growth, and 60.5% recognized HPV as its primary cause. While 62% were aware of the HPV vaccine, only 67% expressed willingness to receive it. Healthcare workers were the main source of information (37.5%). Key barriers included high cost (40%), fear of side effects (30%), and lack of awareness (17.5%). Misconceptions regarding post-vaccination sexual practices were also prevalent.


 


Conclusion: Despite moderate awareness, significant knowledge gaps and misconceptions persist. Enhanced health education, policy-level HPV vaccine integration into national programs, and improved accessibility are critical to increasing vaccine uptake and reducing cervical cancer burden.

Abstract 65 | Pdf Downloads 28

References

1. Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012;33(1):7-12.
2. Murillo R, Ordóñez-Reyes C. Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs. Int J Gynecol Cancer. 2019;29(8):1317-1326.
3. Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening in rural India: Status & current concepts. Indian J Med Res. 2018;148(6):687-696.
4. Pathak P, Pajai S, Kesharwani H. A Review on the Use of the HPV Vaccine in the Prevention of Cervical Cancer. Cureus. 2022;14(9):e28710.
5. Mphuru A, Li AJ, Kyesi F, Mwengee W, Mazige F, Nshunju R, et al. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation. Vaccine. 2022;40:A2-A9.
6. Kaur KN, Niazi F, Nandi D, Taneja N. Gender-Neutral HPV Vaccine in India; Requisite for a Healthy Community: A Review. Cancer Control. 2024;31:10732748241285184.
7. Chan DNS, Li C, Law BMH, Choi KC, Lee PPK, So WKW. Factors affecting HPV vaccine uptake among ethnic minority adolescent girls: A systematic review and meta-analysis. Asia Pac J Oncol Nurs. 2023;10(9):100279.
8. Simms KT, Keane A, Nguyen DTN, et al. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. Nat Med. 2023;29:3050–3058.
9. Nath A, Shalini MAJ, Mathur P. Health systems challenges and opportunities in tackling non-communicable diseases in rural areas of India. Natl Med J India. 2021;34(1):29-35.
10. Bhattacharya S, Garg S, Gopal KM. Empowering India's fight against cervical cancer: Harnessing routine HPV immunisation. J Family Med Prim Care. 2025 Jan;14(1):22-28. doi: 10.4103/jfmpc.jfmpc_678_24. Epub 2025 Jan 13. PMID: 39989547; PMCID: PMC11844949.
11. Gupta S, Kumar P, Das BC. Challenges and opportunities to making Indian women cervical cancer free. Indian J Med Res. 2023 Nov 1;158(5&6):470-475. doi: 10.4103/ijmr.ijmr_1052_23. Epub 2024 Jan 24. PMID: 38237905; PMCID: PMC10878483.
12. Rathod S, Potdar J, Gupta A, Sethi N, Dande A. Empowering Women's Health: Insights Into HPV Vaccination and the Prevention of Invasive Cervical Cancer. Cureus. 2023 Nov 27;15(11):e49523. doi: 10.7759/cureus.49523. PMID: 38156129; PMCID: PMC10752828.
13. Chande HM, Kassim T. Assessment of women's knowledge and attitude towards carcinoma of the cervix in Ilala Municipality. East Afr J Public Health. 2010;7:74-7.
14. Abdullahi A, Copping J, Kessel A, Luck M, Bonell C. Cervical screening: Perceptions and barriers to uptake among Somali women in Camden. Public Health. 2009;123: 680-5.
15. Juntasopeepun, Davidson P, Suwan PM, Phianmongkhol N. Human Papillomavirus Vaccination Intention among Young Women in Thailand. Asian Pacific J Can Preven. 2011;12(12):3213-9.
16. Arunkumar P, Kohila K. Study on awareness of human papillomavirus vaccine. Int J Reprod Contracept Obstet Gynecol 2022;11:2142-6.
17. Mukama T, Ndejjo R, Musabyimana A, Halage AA, Musoke D. Women's knowledge and attitudes towards cervical cancer prevention: a cross sectional study in Eastern Uganda. BMC Womens Health. 2017;17(1):9.
18. Montgomery MP, Dune T, Shetty PK, Shetty AK. knowledge and Acceptability of Human Papillomavirus Vaccination and Cervical Cancer Screening among Women in Karnataka. Ind J Can Educ. 2015;30(1):130-7.
19. Basu P, Sarkar S, Mukherjee S. Women’s perceptions and social barriers determine compliance to cervical screening: Results from a population-based study in India. Can Detect Prev. 2016;30(4):369-74.
20. Charakorn C, Rattanasiri S, Lertkhachonsuk AA, Thanapprapasr D, Chittithaworn S, Wilailak S. Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women. Asia Pac J Clin Oncol. 2011 Jun;7(2):160-7. doi: 10.1111/j.1743-7563.2011.01392.x. PMID: 21585696.

Most read articles by the same author(s)